Gilead Sciences develops and commercializes medicines for unmet medical needs globally. Products include HIV/AIDS treatments Biktarvy, Genvoya, Descovy, etc. Veklury treats COVID-19, while Epclusa, Harvoni, and others treat viral hepatitis. Yescarta, Tecartus, and Trodelvy are oncology treatments. Letairis treats pulmonary arterial hypertension, and AmBisome treats serious fungal infections. The company has multiple collaboration agreements with various partners.
| Indicator | Value |
|---|---|
| PER | 293.9 |
| EV/EBITDA | 11.6 |
| Price/Free Cash Flow' | 13.7 |
| ROIC | 23.5% |
| Net Debt/EBITDA | 1.2 |